injectify retatrutide UK 2026: Phase 3 Results Lost 50lbs in 3 months!

It is still investigational and not approved anywhere, with possible FDA approval around 2027 (GoodRx)

Overall, the reduction was modest but meaningful at the population level, amounting to about 7 fewer cases of any substance use disorder (including nicotine) for every 1,000 people treated

Supported by: Wellcome Trust, Royal Society, NIHR, University of Exeter Disclosure: A.E

DOI: 10.2337/dc16-0917

Im hopeful that within the next few years, well see the results of ongoing studies in this area. Potential drawbacks Preconception GLP-1 receptor agonist use may improve fertility odds for some women, especially those with obesity or PCOS, but these drugs can also come with risk for adverse outcomes